INOPRAN

Film-coated tablet, 150mg
RestrictedActive license

Active substance (INN)

erlotinib

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength150mg
PackagingUkupno 30 film tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EB02)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateSeptember 29, 2022

Analogs in Montenegro

3

Other medicines with the same active substance

Source: CInMED register